Intravenous compared with oral iron for the treatment of iron-deficiency anemia in pregnancy: a systematic review and meta-analysis

Journal of Perinatology

Volumn 39, Issue 4, 2019, Pages 519-532

  Lewkowitz, Adam K ^a   Gupta, Anjlie ^a   Simon, Laura ^a   Sabol, Bethany A ^a   Stoll, Carrie ^a   Cooke, Emily ^b   Rampersad, Roxanne A ^a   Tuuli, Methodius G ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC CARBOXYMALTOSE; FERRITIN; FERROUS ASCORBATE; FERROUS FUMARATE; FERROUS SULFATE; HEMOGLOBIN; IRON; IRON DEXTRAN; IRON POLYMALTOSE; IRON SACCHARATE;

ARTHRALGIA; BIRTH WEIGHT; BLOOD TRANSFUSION; CESAREAN SECTION; CHEST TIGHTNESS; CONSTIPATION; DIARRHEA; DRUG EFFECT; DRUG WITHDRAWAL; FAINTNESS; FEVER; FLUSHING; GASTROINTESTINAL SYMPTOM; GESTATIONAL AGE; HEADACHE; HEARTBURN; HUMAN; HYPERTENSION; HYPOTENSION; INJECTION SITE IRRITATION; IRON DEFICIENCY ANEMIA; LETHARGY; META ANALYSIS; METALLIC TASTE; MYALGIA; NAUSEA; OBSTETRIC DELIVERY; PREGNANCY; PRURITUS; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; TACHYCARDIA; TREATMENT OUTCOME; URTICARIA; VOMITING; BLOOD; COMPARATIVE STUDY; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PREGNANCY COMPLICATION; PROCEDURES;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ANEMIA, IRON-DEFICIENCY; DELIVERY, OBSTETRIC; FEMALE; FERRITINS; HEMOGLOBINS; HUMANS; IRON; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

EID: 85060829857     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/s41372-019-0320-2     Document Type: Review

References (40)

1. WHO. The Global Prevalence of Anaemia in 2011. Geneva: World Health Organization; 2015.
2. Anemia in Pregnancy. ACOG Practice Bulletin No. 95. Obstet Gynecol. 2008;112:201–7.
3. Drukker L, Hants Y, Farkash R, Ruchlemer R, Samueloff A, Grisaru-Granovsky S. Iron deficiency anemia at admission for labor and delivery is associated with an increased risk for Cesarean section and adverse maternal and neonatal outcomes. Transfusion. 2015;55:2799–806.
4. Pavord S, Myers B, Robinson S, Allard S, Strong J, Oppenheimer C. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2012;156:588–600.
5. Achebe MM, Gafter-Gvili A. How I treat anemia in pregnancy: Iron, cobalamin, and folate. Blood. 2017;129:940–9.
6. Tomer A, Amir B, Alon G, Hefziba G, Leonard L, Anat GG. The safety of intravenous iron preparations: Systematic review and meta-analysis. Mayo Clin Proc. 2015;90:12–23.
7. Reveiz L, Gyte GML, Cuervo LG. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev. 2011: Art No.: CD003094.
8. Shi Q, Leng W, Wazir R, Li J, Yao Q, Mi C, et al. Intravenous iron sucrose versus oral iron in the treatment of pregnancy with iron deficiency anaemia: a systematic review. Gynecol Obstet Invest. 2015;80:170–8.
9. Qassim A, Mol BW, Grivell RM, Grzeskowiak LE. Safety and efficacy of intravenous iron polymaltose, iron sucrose and ferric carboxymaltose in pregnancy: a systematic review. Aust New Zeal J Obstet Gynaecol. 2017;58:1–18.
10. Kochhar PK, Kaundal A, Ghosh P. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial. J Obstet Gynaecol Res. 2013;39:504–10.
11. Abhilashini GD, Sagili H, Reddi R. Intravenous iron sucrose and oral iron for the treatment of iron deficiency anaemia in pregnancy. J Clin Diagn Res. 2014;8:Oc04–7.
12. MN M, Shah J. Iron deficiency anemia in pregnancy: Intravenous versus oral route. Natl J Community Med. 2014;5:10–12.
13. Rudra S, Chandna A, Nath J. Comparison of intravenous iron sucrose with oral iron in pregnant women with iron deficiency anaemia. Int J Reprod Contracept Obstet Gynecol. 2016;5:747–51.
14. Khalafallah AA, Hyppa A, Chuang A, Hanna F, Wilson E, Kwok C, et al. A prospective randomised controlled trial of a single intravenous infusion of ferric carboxymaltose vs. single intravenous iron polymaltose or daily oral ferrous sulphate in the treatment of iron deficiency anaemia in pregnancy. Semin Hematol. 2018;55:223–34.
15. Shim JY, Kim MY, Kim YJ, Lee Y, Lee JJ, Jun JK, et al. Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women. BMC Pregnancy Childbirth. 2018;18:1–8.
16. Gupta A, Manaktala U, Rathore AM. A randomised controlled trial to compare intravenous iron sucrose and oral iron in treatment of iron deficiency anemia in pregnancy. Indian J Hematol Blood Transfus. 2014;30:120–5.
17. Darwish AM, Khalifa EE, Rashad E, Farghally E. Total dose iron dextran infusion versus oral iron for treating iron deficiency anemia in pregnant women: a randomized controlled trial. J Matern Neonatal Med. 2017;7058:1–6.
18. Breymann C, Milman N, Mezzacasa A, Bernard R, Dudenhausen J. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP). J Perinat Med. 2017;45:443–53.
19. Abdelazim IA, Abu-Faza M, Elbiaa AAM, Othman HS, Alsharif DA, Elsawah WF. Heme iron polypeptide (Proferrin®—ES) versus iron saccharate complex (ferrosac) for treatment of iron deficiency anemia during pregnancy. Acta Med Int. 2017;4:55–60.
20. Neeru S, Nair NS, Rai L. Iron sucrose versus oral iron therapy in pregnancy anemia. Indian J Community Med. 2012;37:214–8.
21. Shafi D, Purandare SV, Sathe AV. Iron deficiency anemia in pregnancy: intravenous versus oral route. J Obstet Gynaecol India. 2012;62:317–21.
22. Bhavi SB, Jaju PB. Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial. BMC Pregnancy Childbirth. 2017;17:137.
23. Aggarwal R, Mishra V, Panchal N, Patel N, Deshchougule V, Anil J. Evaluation of iron sucrose and oral iron in management of iron deficiency anaemia in pregnancy. 2012;3:55–60.
24. Khalafallah A, Dennis A, Bates J, Bates G, Robertson IK, Smith L, et al. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy. J Intern Med. 2010;268:286–95.
25. Moher D, Liberati ATJ, AD. ThePRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–9.
26. Institute of Medicine. Finding what works in health care: standards for systematic reviews. Medicine. 2011;26:2–4.
27. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.handbook.cochrane.org.
28. McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40–46.
29. Yu L, Kronen RJ, Simon LE, Stoll CRT, Colditz GA, Tuuli MG. Prophylactic negative-pressure wound therapy after cesarean is associated with reduced risk of surgical site infection: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;218:200–210.e1.
30. Tuuli MG, Frey HA, Odibo AO, MacOnes GA, Cahill AG. Immediate compared with delayed pushing in the second stage of labor: a systematic review and meta-analysis. Obstet Gynecol. 2012;120:660–8.
31. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.
32. Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Heal. 2014;72:1–10.
33. UN. Country Classification System. 2014. http://web.worldbank.org/WBSITE/EXTERNAL/DATASTATISTICS/0,contentMDK:20421402~pagePK:64133150~piPK:64133175~theSitePK:239419,00.html#Low_income. Accessed February 5, 2007.
34. Stuck AE, Rubenstein LZ, Wieland D, Vandenbroucke JP, Irwig L, Macaskill P, et al. Bias in meta-analysis detected by a simple, graphical. Br Med J. 1998;316:469–469.
35. Bhargava R, Maheshwari M. Evaluation of intravenous iron versus oral iron in management of iron deficiency anemia in pregnancy with specific reference to body iron store. J Evol Med Dent Sci. 2013;2:2750–5.
36. Halimi S, Halimi SMA, Shoaib M. Oral versus parenteral iron therapy for correction of iron deficiency anaemia in pregnancy. Gomal J Med Sci. 2011;9:3–5.
37. Al R, Unlubilgin E, Kandemir O, Yalvac S, Cakir L, Haberal A. Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial. Obstet Gynecol. 2005;106:1335–40.
38. Bayoumeu F, Subiran-Buisset C, Baka N-E, Legagneur H, Monnier-Barbarino P, Laxenaire MC. Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. Am J Obstet Gynecol. 2002;186:518–22.
39. al-Momen AK, Al-Meshari A, Al-Nuaim L, Saddique A, Abotalib Z, Khashogji T, et al. Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. Eur J Obstet Gynecol Reprod Biol. 1996;69:121–4.
40. Singh K, Fong YF, Kuperan P. A comparison between intravenous iron polymaltose complex (Ferrum Hausmann) and oral ferrous fumarate in the treatment of iron deficiency anaemia in pregnancy. Eur J Haematol. 1998;60:119–24.